2020
Miller B, Yao W, Dean R, Jensen I , Cyr PL , Slocomb T. Understanding the impact of XLMTM on parents and caregivers in the US: An analysis of survey results. ISPOR 18th Annual European Meeting, Milan Italy, 2020.
Publication: Abstracts and Presentations
/ Topics: Epidemiology
Jensen IS , Hathway J, Cyr PL , Gauden D, Gardiner P. 2020. Cost–consequence analysis of 18 F-fluciclovine for the staging of recurrent prostate cancer. J Mark Access Health Pol 8(1):1749362; doi: 10.1080/20016689.2020.1749362 .
View Abstract
Publication: Manuscripts
/ Topics: Cancer , Epidemiology , Health Economics and Outcomes Research (HEOR)
Hathway J, Miller-Wilson L, Jensen I , Ozbay B, Regan C, Jena A, et al. 2020. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives. J Med Econ 23(6):581-592; doi: 10.1080/13696998.2020.1730123 .
View Abstract
Publication: Manuscripts
/ Topics: Cancer , Health Economics and Outcomes Research (HEOR)
Sacks NC , Everson K, Emden MR, Cyr PL , Wood DR, Raza S, Wood KA, Pokorney SD. 2020. Disparities in the management of newly diagnosed paroxysmal supraventricular tachycardia for women versus men in the United States. J Am Heart Assoc 9(19):e015910; 10.1161/JAHA.120.0159 .
View Abstract
Publication: Manuscripts
/ Topics: Epidemiology
Sacks NC , Cyr PL , Preib MT, Everson K, Wood DR, Raza S, Pokorney SD. 2020. Healthcare resource use and expenditures in patients newly diagnosed with paroxysmal supraventricular tachycardia. Am J Cardiol 125(2):215–221; doi: 10.1016/j.amjcard.2019.10.015 .
View Abstract
Publication: Manuscripts
/ Topics: Health Economics and Outcomes Research (HEOR)
Dean R, Miller B, Arjunji R, Feltner DE, Sproule DM, Jensen I , Dabbous O. Cost-utility analysis of single dose gene-replacement therapy for spinal muscular atrophy type 1 compared to chronic nusinersen treatment in Japan. Abstract PMU36 , ISPOR 2020.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Hathway J, Miller-Wilson L, Jensen I , Ozbay B, Regan C, Yao W, et al. Budget impact of improving adherence to colorectal cancer screening. Abstract PCN148 , ISPOR 2020.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Cancer , Health Economics and Outcomes Research (HEOR)
Hathway J, Miller-Wilson L, Jensen I , Ozbay B, Regan C, Yao W, et al. The impact of increasing mt-sDNA use among colorectal cancer screeners in a US employer population. Abstract PCN145 , ISPOR 2020.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Cancer , Health Economics and Outcomes Research (HEOR)
Su J, Bylsma LC , Jiang X , Morales Arias J, Jain N, Nordyke RJ . 2020. Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States. J Med Econ 23(8):902-907; doi: 10.1080/13696998.2020.1764006 .
View Abstract
Publication: Manuscripts
/ Topics: Health Economics and Outcomes Research (HEOR)
Bylsma LC , Dean R, Lowe K, Sangare L, Alexander D, Fryzek J. The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta-analysis of patient and study characteristics. Poster for Society of Toxicology 59th Annual Meeting, Virtual, 2020.
View Abstract
A Division of